Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 223.00
+6.40 (2.95%)
May 27, 2026, 4:09 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 20.17 billion as of May 27, 2026. Its market cap has increased by 7.34% in one year.
Market Cap
20.17B
Enterprise Value
16.57B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
223.00
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 20.17B, an increase of 15.14%. That is a compound annual growth rate of 13.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 20.17B | -24.37% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 29.06B |
| InnoCare Pharma | 24.45B |
| Metis TechBio | 18.87B |
| Keymed Biosciences | 17.82B |
| TransThera Sciences (Nanjing) | 16.41B |
| Zai Lab | 16.24B |
| Ascletis Pharma | 15.55B |
| Ascentage Pharma Group International | 14.52B |